Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neuroprotective effects and improved motor performance with metal-chelating agent in PD

Dec. 5, 2008

Inhibition of nigrostriatal-thalamic pathway by Trap-101 beneficial in model of PD

Dec. 5, 2008

MonoSol Rx and Strativa complete bioequivalence studies for ondansetron thin film NDA

Dec. 5, 2008

New positive modulator of GABA-B receptors identified at Novartis

Dec. 4, 2008

Mechanistically distinct drugs developed by PainCeptor, effective in pain models

Dec. 4, 2008

Two pivotal HZT-501 phase III trials meet primary endpoints

Dec. 4, 2008

Questcor resubmits sNDA to FDA for H.P. Acthar Gel for infantile spasms

Dec. 4, 2008

sPLA2 inhibition beneficial in animal models of spinal cord injury

Dec. 3, 2008

Recent Teva and Roche patents disclose new antipsychotic agents

Dec. 3, 2008

TorreyPines reports results from study of NGX-426 in capsaicin-induced pain

Dec. 2, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...